Syracuse's obesity rate against Onondaga County and New York State, the NYRx weight-loss exclusion, a price-opacity finding inside city limits, and a re-designated low-income shortage area.
41.5% of Syracuse adults have obesity (crude prevalence, CDC PLACES 2025 release) 1, against Onondaga County's 36.9% 2 and New York State's 28.0% 3. The state figure comes from a different CDC survey methodology, BRFSS direct survey, than the city and county figures, which are PLACES small-area model estimates, so the 13.5-point gap is directional rather than a like-for-like comparison.
In a city of 146,091 with a median household income of $51,770 4, the local GLP-1 question is not whether specialists exist, because they do, but whether anyone will tell you a price.
New York's Medicaid pharmacy program, NYRx, categorically excludes drugs used for the treatment of anorexia, weight loss or weight gain, confirmed verbatim in the primary eMedNY NYRx Pharmacy Policy Guidelines (version 2026-2, March 2026), citing Social Security Act §1927(d)(2) 16. That sweeps in Wegovy, Zepbound, and Saxenda when prescribed for chronic weight management.
The same molecules, Ozempic, Mounjaro, Trulicity, Rybelsus, and Victoza, remain covered under NYRx when prescribed for type 2 diabetes with standard prior authorization; that brand-name split is a reasonable inference from the indication-based exclusion, not an itemized statement in the primary document 16. Nationally, KFF found only 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service as of January 2026, and New York was not among them in any source checked 15.
This is a price-opacity finding, not a price table: zero verified in-city providers publish a GLP-1 price. Slim Weight Loss Clinic at 120 E Washington St downtown is the only address of all providers checked that the Census Bureau geocoder confirms sits inside true Syracuse city limits (GEOID 3673000), and its site publishes no semaglutide or tirzepatide price, routing visitors to a consultation-request form, confirmed by direct fetch with no dollar figure anywhere on the page (checked Aug 28, 2026) 149.
The two nearby clinics that do publish prices are outside the city line. Flawless Image Medical Aesthetics at 5805 Bridge St geocodes to the Village of East Syracuse, Town of DeWitt, and publishes GLP-1/GIP injectable pricing at $360/month cash or $385/month by card for months one through three, rising to $360 to $475/month thereafter depending on dose, with free consultations and labs and no contract; the page does not pair a specific semaglutide dose figure with that price, so it is a general GLP-1/GIP rate 12. Captivate IV Wellness & Beauty Bar at 4306 E Genesee St carries a Syracuse 13214 postal designation but returns no incorporated-place match in the Census geocoder, indicating unincorporated DeWitt, and publishes a bundled SLIM membership starting at $175/month covering provider check-ins, labs, body-composition scans, and infrared sauna rather than an itemized drug price 13.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year, identical in every city.
SUNY Upstate Medical University runs a Joslin-Diabetes-Center-affiliated Division of Endocrinology, Diabetes, and Metabolism and a Bariatric and Metabolic Surgery Program accredited as a Comprehensive Center under MBSAQIP, genuine specialist depth for a market this size 1011. That academic-referral pathway exists alongside, not instead of, a documented primary-care access gap: it requires insurance and referral, not same-week cash-pay access.
HRSA's active Low-Income Population Primary Care HPSA, LI-Syracuse RSA-52 (HPSA ID 1366668191), was re-designated 03/26/2026 across 59 census tracts in Onondaga County: score 16 of 26, a population-to-provider ratio of 8,219:1 against a 3,000:1 goal, and a designation population of 74,537, of whom 27.9% are below the poverty line. A parallel Low-Income Population Mental Health HPSA, LI-City of Syracuse RSA 52, score 19, covers the same population, and two facility-based designations sit inside city limits, Syracuse Community Health Center Inc at 819 S Salina St (PC score 18, MH score 20, continuously designated since 2003) and Liberty Resources Inc at 1045 James St (PC score 20, MH score 16, designated 2023). A separate Medicaid-Eligible-Population geographic HPSA covering overlapping tracts was withdrawn 07/01/2026, so the Low-Income Population designation is the one currently in force 78.
A direct telehealth evaluation answers the specific thing Syracuse lacks: a published price and an appointment that does not depend on a referral or a drive out to DeWitt. The New York GLP-1 overview covers statewide rules.
Astra treats patients in New York through state-licensed physicians.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. A licensed physician decides whether treatment is appropriate for you.
Monthly self-pay prices published by local providers, compared with Astra's online programs and the manufacturers' own self-pay prices for brand-name drugs. Compounded and brand-name medications are different products; compounded medications are not FDA-approved.
| Provider | Per month | Basis | Source |
|---|---|---|---|
| Flawless Image Medical Aesthetics | $360–$475 | per month; $360 cash months 1-3 ($385 card), then $360-$475 by dose | source, checked 2026-08-28 |
| Astra — compounded semaglutide | $68 | per month, 12-month plan | program page |
| Astra — compounded tirzepatide | $118 | per month, 12-month plan | program page |
| Wegovy pen — NovoCare self-pay | $349 | per month, standard price | price index |
| Zepbound® — LillyDirect self-pay | $299–$449 | per month, by dose | price index |
Yes — online, for patients in New York. Astra has two current promo codes:
Code
Compounded tirzepatide: code NEWSTART — $100 off. $109/mo instead of $118/mo on the 12-month plan ($1,316 billed once instead of $1,416).
Apply NEWSTART automatically →Code
Compounded semaglutide: code Sema NewStart — $30 off. Applied at checkout; plans start at $68/mo on the 12-month plan ($816 billed once) before the discount.
Apply Sema NewStart automatically →Click a button to start with the code already applied, or type the code during checkout. NEWSTART applies to the 12-month compounded tirzepatide plan. Plans are billed upfront, renew automatically and can be cancelled any time. A licensed physician decides whether treatment is appropriate; a visit does not guarantee a prescription. Compounded medications are not FDA-approved. Subscription terms · Refund policy. Last verified 2026-10-01.
All Astra promo codes · Semaglutide coupon guide · Tirzepatide coupon guide
No clinic verified to sit inside Syracuse city limits publishes a semaglutide or tirzepatide price on its own site. The nearest published prices sit just outside the city line, in East Syracuse and DeWitt: GLP-1/GIP injectables starting around $360/mo cash for the first 3 months (rising to $360-$475/mo after), or a bundled weight-loss membership from $175/mo. Astra's price is the same in Syracuse as everywhere else Astra operates: $68/mo for semaglutide or $118/mo for tirzepatide, on 12-month plans ($816 / $1,416 billed annually).
Yes. HRSA's currently active Low-Income Population Primary Care HPSA covering Syracuse (re-designated 03/26/2026) shows a population-to-provider ratio of 8,219:1 against a 3,000:1 goal, across a designation population of 74,537 people, 27.9% of whom live below the poverty line. A parallel Mental Health HPSA covers the same population.
Syracuse's adult obesity rate is 41.5% (crude prevalence, CDC PLACES, BRFSS 2023) versus 36.9% for Onondaga County and 28.0% for New York State overall (CDC BRFSS state survey, same year) — a 13.5-point city-to-state gap. The state figure uses a different survey methodology than the city/county small-area model, so treat the exact gap size as directional.
No. NYRx, New York Medicaid's pharmacy program, excludes drugs prescribed for weight loss under Social Security Act §1927(d)(2), per the state's current pharmacy policy guidelines (March 2026). The same drugs remain covered when prescribed for type 2 diabetes. New York is not among the 13 states KFF identified as covering GLP-1s for obesity under Medicaid fee-for-service as of January 2026.
There's no verified in-city price to compare against — no clinic confirmed inside Syracuse city limits publishes one. Against the nearest published local prices (just outside the city, in East Syracuse and DeWitt), which start around $175-$420/mo and can rise after an introductory period, Astra's flat $68/mo semaglutide or $118/mo tirzepatide is lower on a like-for-like monthly basis — but the honest comparison here is Astra's price transparency versus a local market where most nearby providers don't publish a price at all.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.